Tomudex (raltitrexed) - injectable cytotoxic agent for treatment of advanced colorectal cancer

Tomudex (now a trademark of Hospira) (raltitrexed)


Please note: Tomudex is now a trademark of Hospira. It continues to be produced and distributed by AstraZeneca in certain markets on Hospira's behalf. Tomudex (raltitrexed) is an injectable cytotoxic agent for advanced colorectal cancer. It was developed as part of a collaboration with the Institute for Cancer Research in the UK and the British Technology Group.

Did you know?

AstraZeneca has a range of product specific and disease area websites for international healthcare professionals and patients. Links to this information can be found below.

Healthcare professionals

Patients and families opens in a new window

Links to country-specific websites can be found using the AstraZeneca websites list.

If you still have a question regarding our drug portfolio you can Contact us.